Background/Aims: Gastric xanthomas are frequently observed in the stomach as small yellowish plaques or nodules. A close relationship among Helicobacter pylori infection, atrophic gastritis, and xanthomas has been reported. We assessed the clinicopathological features of gastric cancer with or without xanthomas. Methods: A total of 91 patients who were diagnosed as having early gastric cancer were enrolled. We evaluated the gastritis status using scores for gastritis and atrophy, positivity of H. pylori infection, the prevalence rate of xanthomas, and the clinicopathological features of gastric cancer. Results: Gastric xanthomas were observed in 72.5% of early gastric cancer cases. Scores for gastritis and atrophy were significantly higher in the xanthoma-positive group than those in the xanthoma-negative group. A higher prevalence of differentiated-type adenocarcinoma was found in the xanthoma-positive group. Among the cases with multiple gastric xanthomas, the prevalence of males was significantly higher than that of females. Conclusion: A high prevalence rate of gastric xanthomas in gastric cancer cases was shown. Xanthomas were highly associated with age, the severities of gastritis and atrophy, and differentiated-type adenocarcinoma. Regardless of the eradication of H. pylori, xanthomas may be useful predictive markers for the development of differentiated-type adenocarcinoma.

Journal Section:
Original Paper
Keywords:
Helicobacter pylori, Atrophic gastritis, Endoscopy, Early gastric cancer
1.
Siegel R, Naishadham D, Jemal A: Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
https://doi.org/10.3322/caac.21166</pub-id><pub-id pub-id-type="pmid">23335087
2.
Shinomura Y: Trends in gastrointestinal diseases in Japan. Digestion 2016;93:5-6.
[PubMed]
https://doi.org/10.1159/000441805
3.
Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ: Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001;345:784-789.
[PubMed]
https://doi.org/10.1056/NEJMoa001999
4.
Shichijo S, Hirata Y, Sakitani K, Yamamoto S, Serizawa T, Niikura R, Watabe H, Yoshida S, Yamada A, Yamaji Y, Ushiku T, Fukayama M, Koike K: Distribution of intestinal metaplasia as a predictor of gastric cancer development. J Gastroenterol Hepatol 2015;30:1260-1264.
[PubMed]
https://doi.org/10.1111/jgh.12946
5.
Masuyama H, Yoshitake N, Sasai T, Nakamura T, Masuyama A, Zuiki T, Kurashina K, Mieda M, Sunada K, Yamamoto H, Togashi K, Terano A, Hiraishi H: Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk. Digestion 2015;91:30-36.
[PubMed]
https://doi.org/10.1159/000368807
6.
Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, Terao S, Amagai K, Hayashi S, Asaka M; Japan Gast Study Group: Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet 2008;372:392-397.
[PubMed]
https://doi.org/10.1016/S0140-6736(08)61159-9
7.
Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS; China Gastric Cancer Study Group: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004;291:187-194.
https://doi.org/10.1001/jama.291.2.187</pub-id><pub-id pub-id-type="pmid">14722144
8.
Ito M, Takata S, Tatsugami M, Wada Y, Imagawa S, Matsumoto Y, Takamura A, Kitamura S, Matsuo T, Tanaka S, Haruma K, Chayama K: Clinical prevention of gastric cancer by Helicobacter pylori eradication therapy: a systematic review. J Gastroenterol 2009;44:365-371.
[PubMed]
https://doi.org/10.1007/s00535-009-0036-8
9.
Lee YC, Chiang TH, Chou CK, Tu YK, Liao WC, Wu MS, Graham DY: Association between Helicobacter pylori eradication and gastric cancer incidence: a systematic review and meta-analysis. Gastroenterology 2016;150:1113-1124.e5.
[PubMed]
https://doi.org/10.1053/j.gastro.2016.01.028
10.
Majima A, Handa O, Naito Y, Dohi O, Okayama T, Yoshida N, Kamada K, Katada K, Uchiyama K, Ishikawa T, Takagi T, Konishi H, Yagi N, Itoh Y: Early-stage gastric cancer can be found in improved atrophic mucosa over time from successful Helicobacter pylori eradication. Digestion 2017;95:194-200.
[PubMed]
https://doi.org/10.1159/000460245
11.
Shiotani A, Haruma K, Graham DY: Metachronous gastric cancer after successful Helicobacter pylori eradication. World J Gastroenterol 2014;20:11552-11559.
[PubMed]
https://doi.org/10.3748/wjg.v20.i33.11552
12.
Yoon SB, Park JM, Lim CH, Cho YK, Choi MG: Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors: a meta-analysis. Helicobacter 2014;19:243-248.
[PubMed]
https://doi.org/10.1111/hel.12146
13.
Maehata Y, Nakamura S, Fujisawa K, Esaki M, Moriyama T, Asano K, Fuyuno Y, Yamaguchi K, Egashira I, Kim H, Kanda M, Hirahashi M, Matsumoto T: Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc 2012;75:39-46.
[PubMed]
https://doi.org/10.1016/j.gie.2011.08.030
14.
Kong YJ, Yi HG, Dai JC, Wei MX: Histological changes of gastric mucosa after Helicobacter pylori eradication: a systematic review and meta-analysis. World J Gastroenterol 2014;20:5903-5911.
[PubMed]
https://doi.org/10.3748/wjg.v20.i19.5903
15.
Kodama M, Murakami K, Okimoto T, Sato R, Uchida M, Abe T, Shiota S, Nakagawa Y, Mizukami K, Fujioka T: Ten-year prospective follow-up of histological changes at five points on the gastric mucosa as recommended by the updated Sydney system after Helicobacter pylori eradication. J Gastroenterol 2012;47:394-403.
[PubMed]
https://doi.org/10.1007/s00535-011-0504-9
16.
Kang JM, Kim N, Shin CM, Lee HS, Lee DH, Jung HC, Song IS: Predictive factors for improvement of atrophic gastritis and intestinal metaplasia after Helicobacter pylori eradication: a three-year follow-up study in Korea. Helicobacter 2012;17:86-95.
[PubMed]
https://doi.org/10.1111/j.1523-5378.2011.00918.x
17.
Kato M, Terao S, Adachi K, Nakajima S, Ando T, Yoshida N, Uedo N, Murakami K, Ohara S, Ito M, Uemura N, Shimbo T, Watanabe H, Kato T, Ida K; Study Group for Establishing Endoscopic Diagnosis of Chronic Gastritis: Changes in endoscopic findings of gastritis after cure of H. pylori infection: multicenter prospective trial. Dig Endosc 2013;25:264-273.
[PubMed]
https://doi.org/10.1111/j.1443-1661.2012.01385.x
18.
Kaiserling E, Heinle H, Itabe H, Takano T, Remmele W: Lipid islands in human gastric mucosa: morphological and immunohistochemical findings. Gastroenterology 1996;110:369-374.
[PubMed]
https://doi.org/10.1053/gast.1996.v110.pm8566582
19.
Hirokawa M, Takenaka R, Takahashi A, Sugihara K, Wada H, Tashiro T, Horiguchi H, Wakatsuki S, Sano T: Esophageal xanthoma: report of two cases and a review of the literature. J Gastroenterol Hepatol 2003;18:1105-1108.
[PubMed]
https://doi.org/10.1046/j.1440-1746.2003.02844.x
20.
Nakasono M, Hirokawa M, Muguruma N, Okahisa T, Okamura S, Ito S, Miyamoto H, Wada S, Fukuda T, Sano T: Colorectal xanthomas with polypoid lesion: report of 25 cases. APMIS 2004;112:3-10.
[PubMed]
https://doi.org/10.1111/j.1600-0463.2004.apm1120102.x
21.
Gravina AG, Iacono A, Alagia I, D'Armiento FP, Sansone S, Romano M: Gastric xanthomatosis associated with gastric intestinal metaplasia in a dyspeptic patient. Dig Liver Dis 2009;41:765.
[PubMed]
https://doi.org/10.1016/j.dld.2008.08.003
22.
Hirasaki S, Kubo M, Inoue A: Gastric hyperplastic polyp associated with proliferation of xanthoma cells observed by magnification narrow-band imaging endoscopy. Gastroenterol Res Pract 2009;2009:845260.
[PubMed]
https://doi.org/10.1155/2009/845260
23.
Muraoka A, Suehiro I, Fujii M, Ueno H, Hayashi S, Shimizu K, Kitazawa R, Kitazawa S, Murakami K: Type IIa early gastric cancer with proliferation of xanthoma cells. J Gastroenterol 1998;33:326-329.
[PubMed]
24.
Isomoto H, Mizuta Y, Inoue K, Matsuo T, Hayakawa T, Miyazaki M, Onita K, Takeshima F, Murase K, Shimokawa I, Kohno S: A close relationship between Helicobacter pylori infection and gastric xanthoma. Scand J Gastroenterol 1999;34:346-352.
[PubMed]
https://doi.org/10.1080/003655299750026344
25.
Hori S, Tsutsumi Y: Helicobacter pylori infection in gastric xanthomas: immunohistochemical analysis of 145 lesions. Pathol Int 1996;46:589-593.
[PubMed]
https://doi.org/10.1111/j.1440-1827.1996.tb03658.x
26.
Sekikawa A, Fukui H, Maruo T, Tsumura T, Kanesaka T, Okabe Y, Osaki Y: Gastric xanthelasma may be a warning sign for the presence of early gastric cancer. J Gastroenterol Hepatol 2014;29:951-956.
[PubMed]
https://doi.org/10.1111/jgh.12512
27.
Sekikawa A, Fukui H, Sada R, Fukuhara M, Marui S, Tanke G, Endo M, Ohara Y, Matsuda F, Nakajima J, Henmi S, Saito S, Tsumura T, Maruo T, Kimura T, Osaki Y: Gastric atrophy and xanthelasma are markers for predicting the development of early gastric cancer. J Gastroenterol 2016;51:35-42.
[PubMed]
https://doi.org/10.1007/s00535-015-1081-0
28.
Japanese Gastric Cancer Association: Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 2011;14:101-112.
[PubMed]
https://doi.org/10.1007/s10120-011-0041-5
29.
Endoscopic Classification Review Group: Update on the Paris classification of superficial neoplastic lesions in the digestive tract. Endoscopy 2005;37:570-578.
[PubMed]
https://doi.org/10.1055/s-2005-861352
30.
Kimura K, Takemoto T: An endoscopic recognition of the atrophic border and its significance in chronic gastritis: Endoscopy 1969;3:87-97.
https://doi.org/10.1055/s-0028-1098086
31.
Haruma K, Kato M, Inoue K, Murakami K, Kamata T (eds): Kyoto Classification of Gastritis. Nihon Medical Center, 2017.
32.
Takenaka R, Okada H, Kato J, Makidono C, Hori S, Kawahara Y, Miyoshi M, Yumoto E, Imagawa A, Toyokawa T, Sakaguchi K, Shiratori Y: Helicobacter pylori eradication reduced the incidence of gastric cancer, especially of the intestinal type. Aliment Pharm Ther 2007;25:805-812.
[PubMed]
https://doi.org/10.1111/j.1365-2036.2007.03268.x
33.
Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, Soda M, Ioka A, Sobue T, Nishimoto H: An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013. Jpn J Clin Oncol 2015;45:390-401.
[PubMed]
https://doi.org/10.1093/jjco/hyv002
© 2017 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2017
You do not currently have access to this content.